Skip to content
2000
Volume 24, Issue 39
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Atherosclerosis provokes a continuous worsening of affected vessels causing a blood flow diminution with several complications and with clinical manifestations that generally appear in advanced phases of the illness. Hence, the conventional therapies are not enough because the atherosclerotic injuries are often irrevocable. For this reason, emerges the necessity to implement smart ways of drug supply and develop new therapeutic targets that decrease the advance atherosclerotic lesion. It results due to particular interest to use new tools for prevention, diagnosis, and treatment of this cardiovascular disease, thus concentrating our attention to accomplish better management on the immune system. Finally, this mini-review highlights the most recent knowledge about nanotechnology as a robust, novel and promissory therapeutic option applied to atherosclerotic pathology, nevertheless, we also alert for possible issues associated with their use.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612825666190110154609
2018-11-01
2025-06-20
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612825666190110154609
Loading

  • Article Type:
    Review Article
Keyword(s): atherosclerosis; blood flow; diagnosis; immune system; nanotechnology; treatment
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test